Nomura Asset Management
AVNS

Nomura Asset Management’s Avanos Medical AVNS Stock Holding History

Nomura Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-960
Closed -$36K – 983
2016
Q4 		$36K Buy
+960
New +$34.3K ﹤0.01% 1205

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nomura Asset Management's AVNS Position: Q1 2017 in Review

Nomura Asset Management sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 960 shares — an estimated $36K sold.

Nomura Asset Management first reported a position in AVNS in Q4 2016 and held it in 1 quarter. The position peaked at $36K in Q4 2016. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

  • Nomura Asset Management reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
  • Nomura Asset Management sold 960 Avanos Medical shares in Q1 2017, an estimated $36K.
  • Nomura Asset Management first reported a position in Avanos Medical in Q4 2016 and held it in 1 quarter.
  • Nomura Asset Management's Avanos Medical position peaked at $36K in Q4 2016.
  • 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on Nomura Asset Management's 13F filing for Q1 2017, filed 12 May 2017.